Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > LBL will do well

<< Previous

Bullboard Posts

Next >>

Comment by MaterialWorldon Feb 15, 2021 4:56pm

142 Views

Post# 32569529

RE:RE:RE:RE:LBL will do well

Hi edrouin. Here is the info you asked for.

The American Dental Association issued guidance in mid March 2020 that all US Dental procedures be considered non essential. This was in the LBL NR dated January 28, 2021 and was for the year end September 28, 2020 4th quarter under 2020 Business update. Hope this will help........hold tight......MW
Once this guidance is lifted, it's showtime.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023